Press Release: Pharm-Olam : Pharm-Olam is now enrolling UK volunteers into a pivotal Phase III COVID-19 vaccine study

HOUSTON, May 20, 2021 /PRNewswire/ -- Pharm-Olam, a global, midsized CRO offering full-service clinical development solutions for infectious diseases, vaccines, rare diseases, and oncology, is now enrolling UK volunteers into a pivotal Phase III COVID-19 vaccine study. Visit...